Home » Newsletters » BioWorld Science

BioWorld Science

May 28, 2009

View Archived Issues

Erythromycin shows efficacy in GERD in infants in clinical trial

ProMaxx formulation of inhaled insulin rapid and safe in healthy volunteers

Pregabalin may improve uremic pruritus in hemodialysis patients

Orchid Chemicals & Pharmaceuticals describes novel HDAC inhibitors as oncolytic compounds

Novel P2X3 receptor antagonists claimed by Merck & Co. as analgesics

Chugai and Gene Bridges expand license agreement for Red/ET recombineering technology

Gruenenthal describes novel progesterone receptor ligands as contraceptives

GlaxoSmithKline discovers novel chemokine CCR5 receptor antagonists for the treatment of HIV

Bristol-Myers Squibb claims glucocorticoid receptor modulators for the treatment of obesity

ACCOMPLISH trial shows benazepril regimens have same CV effect in kidney disease patients

ImmunoVaccine Technologies collaborates with FIT Biotech for HIV vaccine

Takeda licenses H. influenzae vaccine Vaxem Hib from Novartis

CEL-SCI initiates preclinical testing of treatment for swine flu and related H1N1 flu viruses

UCB launches Vimpat in the U.S. for add-on treatment of epilepsy in adults

Agennix presents update on clinical development of talactoferrin for RCC and NSCLC

XG-102 efficacious in mouse model of hemorrhagic stroke

ATHENA post-hoc analysis finds stroke risk reduction with dronedarone antiarrhythmic treatment

Vertex initiates phase III registration program for VX-770 in cystic fibrosis

Post hoc subanalysis of phase III trials reveals no age-dependent effects of epoetin zeta in CKD

FDA allows Medarex's IND application for phase I MDX-1338 trial

Fate Therapeutics treats first patient in phase Ib FT-1050 stem cell modulator trial

S-Nitrosoglutathione reductase inhibitor N30-6001 shows potential in experimental asthma

Clinical data on inhaled, intravenous alpha-1 antitrypsin from Kamada presented

CombinatoRx reports positive phase II results for CRx-401 in type 2 diabetes

Single doses of MEDI-528 do not affect allergen responses in asthma patients

FDA issues complete response letter to Allergan regarding sBLA for Botox for spasticity

Thomson Reuters makes Disease Briefing on influenza publicly available

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...